Dr. Omar Saavedra is a medical oncologist and clinical investigator currently dedicated entirely to early drug development. He was trained as a clinical researcher at the Vall d’Hebron Institute of Oncology for more than 5 years where he was principal investigator of numerous clinical trials, as well as being part of translational studies in which he continues to work. Currently his work is focused on providing to his patients the latest cancer treatments as next generation immunotherapies, targeted agents and epigenetic therapies.
